Who Benefits From a Prostate Rectal Spacer? Secondary Analysis of a Phase III Trial.

There was little heterogeneity in the likelihood of spacer reducing the risk of declines in bowel QOL across clinical and dosimetric variables. Even for the >95% of plans meeting QUANTEC rectal criteria hydrogel spacer provided potentially meaningful benefit.